SLN
Silence Therapeutics
SLN
SLN
29 hedge funds and large institutions have $183M invested in Silence Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 25 → 29 (+4)
5.78% more ownership
Funds ownership: 11.55% → 17.33% (+5.8%)
Holders
29
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$32.3M | |
| 2 | +$21.1M | |
| 3 | +$12.7M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$10M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$8.31M |
Top Sellers
| 1 | -$7.52M | |
| 2 | -$3.34M | |
| 3 | -$361K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$93.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$34.5K |